Sanofi India Limited (BOM:500674)
India · Delayed Price · Currency is INR 3,369.25
-18.45 (-0.54%)
At close: Jul 27, 2026
Sanofi India Ratios and Metrics
Market cap in millions INR. Fiscal year is January - December.
Millions INR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 77,596 | 94,234 | 140,969 | 185,790 | 134,721 | 181,781 | |
Market Cap Growth | -42.40% | -33.15% | -24.13% | 37.91% | -25.89% | -5.11% |
Enterprise Value | 75,145 | 91,317 | 138,708 | 181,504 | 127,956 | 172,685 |
Last Close Price | 3369.25 | 4036.95 | 5837.75 | 4177.66 | 2837.97 | 3486.02 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 25.05 | 28.84 | 34.09 | 30.82 | 21.71 | 19.25 |
PS Ratio | 4.37 | 5.13 | 7.00 | 9.31 | 4.86 | 6.15 |
PB Ratio | 10.36 | 12.58 | 16.38 | 18.30 | 10.56 | 8.17 |
P/TBV Ratio | 10.37 | 12.59 | 16.41 | 18.44 | 10.60 | 8.19 |
P/FCF Ratio | 18.81 | 22.84 | 33.15 | 94.74 | 35.78 | 33.93 |
P/OCF Ratio | 17.70 | 21.50 | 30.53 | 80.64 | 33.79 | 32.53 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 4.24 | 4.97 | 6.89 | 9.09 | 4.62 | 5.84 |
EV/EBITDA Ratio | 16.22 | 18.78 | 28.59 | 37.45 | 18.32 | 22.91 |
EV/EBIT Ratio | 17.65 | 20.10 | 30.56 | 40.02 | 19.22 | 24.82 |
EV/FCF Ratio | 18.21 | 22.13 | 32.61 | 92.56 | 33.99 | 32.23 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 |
Debt / EBITDA Ratio | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 |
Debt / FCF Ratio | - | 0.04 | 0.05 | 0.10 | 0.06 | 0.05 |
Net Debt / Equity Ratio | -0.33 | -0.33 | -0.31 | -0.37 | -0.77 | -0.68 |
Net Debt / EBITDA Ratio | -0.53 | -0.50 | -0.55 | -0.77 | -1.40 | -2.01 |
Net Debt / FCF Ratio | - | -0.59 | -0.62 | -1.91 | -2.61 | -2.82 |
Asset Turnover | - | 1.28 | 1.21 | 1.05 | 1.08 | 0.99 |
Inventory Turnover | - | 2.24 | 1.71 | 1.80 | 3.01 | 3.48 |
Quick Ratio | - | 0.90 | 0.76 | 0.82 | 1.54 | 2.25 |
Current Ratio | - | 1.63 | 1.53 | 1.92 | 2.17 | 2.85 |
Return on Equity (ROE) | - | 40.59% | 33.45% | 31.83% | 35.45% | 43.48% |
Return on Assets (ROA) | - | 19.81% | 17.06% | 14.97% | 16.21% | 14.55% |
Return on Invested Capital (ROIC) | 62.71% | 60.67% | 53.42% | 66.98% | 94.98% | 63.10% |
Return on Capital Employed (ROCE) | - | 59.50% | 51.90% | 42.60% | 50.00% | 30.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 24, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.99% | 3.47% | 2.93% | 3.25% | 4.61% | 5.20% |
FCF Yield | 5.32% | 4.38% | 3.02% | 1.05% | 2.79% | 2.95% |
Dividend Yield | 3.65% | 3.05% | 2.00% | 4.00% | 6.84% | 5.19% |
Payout Ratio | - | 135.35% | 93.01% | 144.02% | 67.17% | 30.48% |
Total Shareholder Return | 3.63% | 3.05% | 2.00% | 4.00% | 6.84% | 5.19% |